drugset / Trial / NCT00788424
Topical Application of AS101 for the Treatment of Psoriasis
RandomizedParallel-groupDouble-blindTreatment
Summary
This protocol relates to a phase II randomized double blind, placebo controlled study of the AS101 topical application for the treatment of mild to moderate Psoriasis.
Timeline
- Start
- 2008-11
- Primary completion
- 2010-02
- Completion
- 2010-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | TRICHLOROTELLURATE | Small molecule | 4 % | Topical |